Written by
Şevval T
Şevval T Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Liv Hospital Ulus Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics Spec. MD. Gizem Güvener Liv Hospital Ulus Spec. MD. Gizem Güvener Pediatrics Spec. MD. Osman Karlı Liv Hospital Ulus Spec. MD. Osman Karlı Pediatrics Spec. MD. Tamer Ünver Liv Hospital Ulus Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU) Assoc. Prof. MD. Adem Dursun Liv Hospital Vadistanbul Assoc. Prof. MD. Adem Dursun Pediatrics Psyc. Selenay Yücel Keleş Liv Hospital Vadistanbul Psyc. Selenay Yücel Keleş Pediatric Psychology Spec. MD.  Fatih Aydın Liv Hospital Vadistanbul Spec. MD. Fatih Aydın Pediatrics Spec. MD. Dicle Çelik Liv Hospital Vadistanbul Spec. MD. Dicle Çelik Pediatrics Spec. MD. Elif Erdem Özcan Liv Hospital Vadistanbul Spec. MD. Elif Erdem Özcan Pediatrics Spec. MD. Hilal Kızıldağ Liv Hospital Vadistanbul Spec. MD. Hilal Kızıldağ Pediatrics Spec. MD. Mehmet Kılıç Liv Hospital Vadistanbul Spec. MD. Mehmet Kılıç Pediatrics Spec. MD. Ozan Uzunhan Liv Hospital Vadistanbul Spec. MD. Ozan Uzunhan Neonatology Spec. MD. Selami Bayrakdar Liv Hospital Vadistanbul Spec. MD. Selami Bayrakdar Pediatrics Spec. MD. Semra Akkuş Akman Liv Hospital Vadistanbul Spec. MD. Semra Akkuş Akman Pediatrics Asst. Prof. MD. Doruk Gül Liv Hospital Bahçeşehir Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases Prof. MD. Murat Sütçü Liv Hospital Bahçeşehir Prof. MD. Murat Sütçü Pediatric Health and Diseases Prof. MD. Nihat Demir Liv Hospital Bahçeşehir Prof. MD. Nihat Demir Pediatrics Psyc. (Psychologist) Buse Yağmur Liv Hospital Bahçeşehir Psyc. (Psychologist) Buse Yağmur Pediatric Psychology Spec. MD. Cansu Muluk Liv Hospital Bahçeşehir Spec. MD. Cansu Muluk Pediatrics Spec. MD. Dilek Hatipoğlu Liv Hospital Bahçeşehir Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases Spec. MD. Duygu Amine Garavi Liv Hospital Bahçeşehir Spec. MD. Duygu Amine Garavi Pediatrics Spec. MD. Fatih Kaya Liv Hospital Bahçeşehir Spec. MD. Fatih Kaya Pediatric Health and Diseases Spec. MD. Günel Nüsretzade Elmar Liv Hospital Bahçeşehir Spec. MD. Günel Nüsretzade Elmar Pediatrics Spec. MD. Mey Talip Liv Hospital Bahçeşehir Spec. MD. Mey Talip Pediatric Intensive Care Spec. MD. Negın Nahanmoghaddam Liv Hospital Bahçeşehir Spec. MD. Negın Nahanmoghaddam Pediatrics Spec. MD. Nushaba Abdullayeva Liv Hospital Bahçeşehir Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases Spec. MD. Refika İlbakan Hanımeli Liv Hospital Bahçeşehir Spec. MD. Refika İlbakan Hanımeli Pediatrics Spec. MD. Selman Alazab Liv Hospital Bahçeşehir Spec. MD. Selman Alazab Pediatrics Spec. MD. Özden Durmuş Gönültaş Liv Hospital Bahçeşehir Spec. MD. Özden Durmuş Gönültaş Pediatrics Spec. Md. Öznur Ceylan Liv Hospital Bahçeşehir Spec. Md. Öznur Ceylan Pediatric Health and Diseases Assoc. Prof. MD. Aslan Yılmaz Liv Hospital Topkapı Assoc. Prof. MD. Aslan Yılmaz Neonatology Prof. MD. Alpay Çakmak Liv Hospital Topkapı Prof. MD. Alpay Çakmak Pediatrics Spec. MD. Demet Deniz Bilgin Liv Hospital Topkapı Spec. MD. Demet Deniz Bilgin Pediatrics Spec. MD. Nesrin Köseoğlu Liv Hospital Topkapı Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry Spec. MD. Seçil Sözen Liv Hospital Topkapı Spec. MD. Seçil Sözen Pediatrics Spec. MD. Özge Akça Liv Hospital Topkapı Spec. MD. Özge Akça Pediatrics Spec. MD. Şeyma Öz Liv Hospital Topkapı Spec. MD. Şeyma Öz Pediatrics Asst. Prof. MD. Pakize Elif Alkış Liv Hospital Ankara Asst. Prof. MD. Pakize Elif Alkış Pediatrics Prof. MD. Musa Kazım Çağlar Liv Hospital Ankara Prof. MD. Musa Kazım Çağlar Pediatrics Prof. MD. İbrahim Hakan Bucak Liv Hospital Ankara Prof. MD. İbrahim Hakan Bucak Pediatrics Prof.MD. Sevgi Başkan Liv Hospital Ankara Prof.MD. Sevgi Başkan Pediatrics Spec. MD. Büşra Süzen Celbek Liv Hospital Ankara Spec. MD. Büşra Süzen Celbek Pediatrics Spec. MD. Galip Erdem Liv Hospital Ankara Spec. MD. Galip Erdem Pediatrics Spec. MD. Hafsa Uçur Liv Hospital Ankara Spec. MD. Hafsa Uçur Pediatric Health and Diseases Spec. MD. Hidayet Katipoğlu Liv Hospital Ankara Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases Spec. MD. Hüsniye Altan Liv Hospital Ankara Spec. MD. Hüsniye Altan Pediatrics Spec. MD. Mehmet Turfanda Liv Hospital Ankara Spec. MD. Mehmet Turfanda Pediatric Health and Diseases Spec. MD. Mustafa Yücel Kızıltan Liv Hospital Ankara Spec. MD. Mustafa Yücel Kızıltan Pediatrics Spec. MD.  Seral Navdar Liv Hospital Gaziantep Spec. MD. Seral Navdar Pediatric Health and Diseases Spec. MD. Gül Balyemez Liv Hospital Gaziantep Spec. MD. Gül Balyemez Pediatric Health and Diseases Spec. MD. Hasan Avşar Liv Hospital Gaziantep Spec. MD. Hasan Avşar Neonatology Spec. MD. Mert Çakır Liv Hospital Gaziantep Spec. MD. Mert Çakır Pediatrics Spec. MD. Saltuk Buğra Böke Liv Hospital Gaziantep Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases Spec. MD. Özlem Karaoğlu Liv Hospital Gaziantep Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases Spec. MD. İsmail Ersan Can Liv Hospital Gaziantep Spec. MD. İsmail Ersan Can Pediatric Health and Diseases Spec. MD. Şekibe Zehra Doğan Liv Hospital Gaziantep Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases Spec. MD. Gülsenem Sarı Aracı Liv Hospital Samsun Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases Spec. MD. Nazlı Karakullukcu Çebi Liv Hospital Samsun Spec. MD. Nazlı Karakullukcu Çebi Pediatrics Spec. MD. Nezih Akgün Liv Hospital Samsun Spec. MD. Nezih Akgün Pediatric Health and Diseases Spec. MD. Pelin Aytaç Uras Liv Hospital Samsun Spec. MD. Pelin Aytaç Uras Pediatrics MD. VEFA İSAYEVA Liv Bona Dea Hospital Bakü MD. VEFA İSAYEVA Pediatric Health and Diseases Spec. MD.  Elnur Hüseynov Liv Bona Dea Hospital Bakü Spec. MD. Elnur Hüseynov Pediatrics Spec. MD. INARE ELDAROVA Liv Bona Dea Hospital Bakü Spec. MD. INARE ELDAROVA Pediatrics Spec. MD. SADİQ İSMAYILOV Liv Bona Dea Hospital Bakü Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases MD. Dr. Elnur Hüseynov MD. Dr. Elnur Hüseynov Pediatrics Spec. MD. Doğa Sevinçok Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry Spec. MD. Sadık İsmayılov Pediatrics Spec. MD. Melike Akar Liv Hospital Bahçeşehir + Liv Hospital Topkapı Spec. MD. Melike Akar Pediatrics
...
Views
Read Time
...
views
Read Time
Wilms Tumor Solid Tumor
Wilms Tumor Solid Tumor 4

Wilms tumor, also known as nephroblastoma, is a rare cancer in kids. It starts in the kidneys and is a solid tumor. Understanding Wilms tumor assists physicians in discovering improved treatment methods Wilms tumor solid tumor.

We help patients from around the world with top-notch care. Our team works hard to learn more about Wilms tumor. This way, we can give the best treatment to our patients.

Key Takeaways

  • Wilms tumor is a type of cancer that mainly hits kids.
  • It is classified as a solid tumor starting in the kidneys.
  • Understanding Wilms tumor characteristics is key for good treatment.
  • Ongoing research aims to improve treatment strategies for Wilms tumor.
  • Comprehensive support is available for international patients seeking treatment.

Understanding Wilms Tumor: Definition and Classification

Wilms Tumor Solid Tumor
Wilms Tumor Solid Tumor 5

What Defines a Solid Tumor

A solid tumor is a cancer that forms a mass in an organ or tissue. For Wilms tumor, this mass is in the kidney. Solid tumors can be benign or malignant, and their type affects treatment. Wilms tumor is a malignant solid tumor mainly found in children.

The definition of a solid tumor includes its physical and histological features. It’s a mass with a specific location. Histologically, it’s defined by the cells it contains and how they’re arranged. Wilms tumor has cells like those in an embryonic kidney, showing its origin.

Wilms Tumor as a Nephroblastoma

Wilms Tumor Solid Tumor
Wilms Tumor Solid Tumor 6

Classifying Wilms tumor involves its histological features, like blastema, epithelia, and stroma. These elements are key for diagnosing Wilms tumor and differentiating it from other kidney tumors. The National Wilms Tumor Study (NWTS) and the International Society of Pediatric Oncology (SIOP) have set criteria for classifying Wilms tumor based on histology. This guides treatment choices.

Seeing Wilms tumor as a nephroblastoma helps us understand its unique traits. This understanding leads to targeted treatments. The classification also helps in managing the disease, including surgery, chemotherapy, and radiation therapy.

Wilms Tumor Solid Tumor: Characteristics and Features

It’s key to know about Wilms tumor to treat it well in kids. This tumor, also called nephroblastoma, is complex. It needs a detailed plan for diagnosis and treatment.

Physical and Histological Properties

Wilms tumor has physical and histological properties that help doctors diagnose it. It usually looks like a big, single mass in the kidney. It has clear edges from the normal kidney tissue.

Looking at the tumor under a microscope shows its three parts: blastemal, epithelial, and stromal. This mix makes it hard to diagnose at times. But, finding anaplasia, with its big, dark nuclei, is a big clue for doctors.

Solid Tumor Growth Patterns in the Kidney

The solid tumor growth pattern of Wilms tumor is key to its study. It grows by getting bigger, pushing the kidney tissue aside. This can cause the tumor to burst or spread into the veins.

Knowing how Wilms tumor grows helps doctors plan surgery. Tests like ultrasound and MRI are important. They help see how big the tumor is and if it has spread.

In short, understanding Wilms tumor’s traits is vital for treating it in kids. By grasping its physical and histological features, and how it grows, doctors can create better treatment plans.

Epidemiology and Prevalence of Wilms Tumor

Understanding Wilms tumor’s epidemiology is key to finding risk factors and creating effective treatments. This cancer mainly hits kids. It’s important to look at age, gender, where they live, and their ethnicity.

Age and Gender Distribution

Most kids with Wilms tumor are under 7 years old. The highest number of cases is between 3 and 4 years. Girls might get it a bit more than boys, some studies say.

This age pattern suggests that genetics may significantly contribute. It’s why early screening is so important, mainly in high-risk groups.

Geographical and Ethnic Variations

Where you live and your ethnicity can affect your chances of getting Wilms tumor. For example, kids of African descent might get it more often than others. This could mean genetics and environment both matter.

Also, how common Wilms tumor is can change a lot by region and country. Knowing this helps us make better health plans for kids with Wilms tumor everywhere.

Causes and Risk Factors for Wilms Tumor

Understanding Wilms tumor assists physicians in discovering improved treatment methods.

Genetic Predisposition and Syndromes

Genetics play a big role in Wilms tumor. Syndromes like WAGR syndrome (Wilms tumor, Aniridia, Genitourinary anomalies, and mental Retardation) and Denys-Drash syndrome raise the risk. These syndromes have specific genetic changes that make people more likely to get Wilms tumor.

A study found that genetics are a key factor in Wilms tumor. Syndromes like WAGR and Denys-Drash increase the risk a lot.

“Children with genetic syndromes such as WAGR and Denys-Drash syndrome are at a higher risk of developing Wilms tumor.”

Environmental Factors

Environmental factors also play a part in Wilms tumor. Exposure to toxins and parental habits, like smoking, have been linked to it.

  • Parental exposure to certain chemicals
  • Maternal smoking during pregnancy
  • Exposure to ionizing radiation

Even though the evidence is not solid, these factors might increase the risk of Wilms tumor.

Sporadic Cases

Most Wilms tumors happen without a known cause. Researchers are looking into new genetic and environmental factorsfor these cases.

Understanding Wilms tumor’s causes, including genetics, environment, and sporadic cases, is key. It helps us move forward in research and improve care for patients.

Understanding Wilms tumor assists physicians in discovering improved treatment methods.

Cellular Origin and Development

Wilms tumor, or nephroblastoma, starts in special cells called metanephric blastema. These cells are leftover from the early stages of kidney development. They don’t grow into normal kidney cells.

Studies show that these cells grow out of control. This leads to the formation of a tumor.

Molecular Biology and Genetics

Wilms tumor’s growth is linked to genetic changes. Important genes like WT1, CTNNB1, and MYCN play a big role. Changes in these genes can cause cells to grow in the wrong way.

“The genetic landscape of Wilms tumor is complex, involving multiple mutations that contribute to its pathogenesis.”

Here’s how these genes affect Wilms tumor:

GeneFunctionRole in Wilms Tumor
WT1Tumor suppressor geneMutations contribute to tumor development
CTNNB1Involved in cell-cell adhesionAlterations can lead to abnormal cell proliferation
MYCNRegulates cell growth and proliferationAmplification can contribute to tumor aggressiveness

Learning about Wilms tumor’s biology is key to finding new treatments. More research will help doctors improve care for patients.

Clinical Presentation and Symptoms

Wilms tumor is a common kidney cancer in kids. It shows different symptoms that help doctors find it early. These symptoms are divided into two main types: common signs and systemic symptoms. Both are important for diagnosing and treating the disease.

Common Presenting Signs

The most common sign of Wilms tumor is an abdominal mass. Parents or doctors often find it during a check-up. Other signs include:

  • Abdominal swelling or distension
  • Hematuria (blood in the urine)
  • Hypertension due to renal compression or tumor secretion
  • Abdominal pain or discomfort

These signs often come with a mass in the abdomen. This is a key sign for doctors to diagnose.

Systemic Symptoms

Wilms tumor can also show systemic symptoms. These include:

  • Fever
  • Weight loss
  • Loss of appetite
  • Fatigue or malaise

These symptoms can sometimes make it hard to diagnose Wilms tumor early. They might be thought of as other common childhood illnesses.

It’s vital for doctors to know about the symptoms of Wilms tumor. This helps them make the right diagnosis quickly.

Understanding how to diagnose Wilms tumor is key for doctors. They need to make accurate diagnoses and plan effective treatments. Diagnosing Wilms tumor involves using many tools and techniques.

Imaging Techniques

Imaging is very important in diagnosing Wilms tumor. Ultrasound is often the first tool used. It’s non-invasive and helps find the tumor’s location and size.

Computed Tomography (CT) scans and Magnetic Resonance Imaging (MRI) are also used. They give detailed images of the tumor and its surroundings. This helps in planning the treatment.

Laboratory Tests

Laboratory tests are also key in diagnosing Wilms tumor. Blood tests check overall health and look for any signs of a tumor. Urine tests check for blood in the urine, a common symptom.

Physicians integrate imaging, lab tests, and biopsy results to establish a diagnosis.

A biopsy is the primary method for diagnosing Wilms tumor. It involves removing a small piece of tumor tissue. This tissue is then examined under a microscope.

By looking at the tissue, doctors can confirm the diagnosis. They can also see the tumor’s type, which helps in planning the treatment.

A biopsy is the primary method for diagnosing Wilms tumor.

Staging and Classification Systems

North American Staging System

The North American Staging System is a common choice for Wilms tumor. It sorts tumors by how far they’ve spread and what surgery finds.

StageDescription
ITumor limited to the kidney, completely excised
IITumor extends beyond the kidney but is completely excised
IIIResidual non-hematogenous tumor confined to the abdomen
IVHematogenous metastases
VBilateral renal involvement at diagnosis

The National Cancer Institute says, “The staging system used for Wilms tumor is critical for determining the prognosis and treatment plan.”

National Cancer Institute

International Society of Pediatric Oncology Classification

The International Society of Pediatric Oncology (SIOP) classification system focuses on histological classification after chemotherapy.

  • Low-risk tumors
  • Intermediate-risk tumors
  • High-risk tumors

The SIOP system helps in risk stratification and guides treatment intensity.

Both staging systems are vital for managing Wilms tumor. They allow for personalized treatment plans and better outcomes.

Managing Wilms tumor needs a mix of treatments. These include surgery, chemotherapy, and radiation therapy. The right treatment depends on the tumor’s stage, the patient’s age, and genetic factors.

Surgical Approaches

A biopsy is the primary method for diagnosing Wilms tumor.

Chemotherapy Protocols

Chemotherapy is essential in treating Wilms tumor. The treatment plan is based on the tumor’s stage and type. Preoperative chemotherapy helps shrink the tumor before surgery. Postoperative chemotherapy targets any remaining cancer cells.

  • Common chemotherapy drugs include vincristine, actinomycin D, and doxorubicin.
  • The length and strength of chemotherapy depend on the tumor’s risk level.

Radiation Therapy

In some cases, radiation therapy is used for Wilms tumor. It’s mainly for advanced disease or when surgery doesn’t remove all tumor. External beam radiation therapy uses high-energy beams to kill cancer cells.

  1. Radiation therapy is often used for Stage III or IV tumors.
  2. Deciding on radiation therapy depends on the tumor’s response to chemotherapy and surgery.

Combining these treatments can help patients with Wilms tumor. Research and clinical trials are always working to improve these treatments.

Prognosis and Survival Rates

Wilms tumor’s prognosis and survival rates depend on several key factors. Knowing these factors helps predict outcomes and plan follow-up care.

Factors Affecting Prognosis

The prognosis for Wilms tumor depends on several factors. These include the disease’s stage, the tumor’s histology, and how well it responds to treatment. Tumor stage is a major factor, with earlier stages having better outcomes.

The histological classification of the tumor is also important. Tumors are classified as favorable or unfavorable based on cellular characteristics. Patients with favorable histology tend to have higher survival rates.

Long-term Survival Statistics

Survival rates for Wilms tumor have greatly improved thanks to better treatments. Studies show that over 90% of children with Wilms tumor now survive in developed countries.

Stage5-Year Survival Rate (%)10-Year Survival Rate (%)
Stage I95-10090-95
Stage II90-9585-90
Stage III80-8575-80
Stage IV70-7565-70
Stage V50-6045-55

The table shows 5-year and 10-year survival rates for Wilms tumor by stage. It emphasizes the need for early detection and treatment.

We keep tracking the long-term effects of treatment and survival rates. This helps us improve patient outcomes. By understanding what affects prognosis, healthcare providers can create better treatment plans. This improves survival chances and quality of life for patients.

Complications and Long-term Effects

Effective treatment of Wilms tumor requires considering long-term complications. As survival rates improve, it’s key to understand treatment’s long-term effects. This helps in giving full care to patients.

Treatment-related Complications

Treatment for Wilms tumor can lead to various complications. Surgical issues might include bowel obstruction or adhesions. Chemotherapy can cause ototoxicity, cardiotoxicity, and nephrotoxicity.

Radiation therapy may result in scoliosis, secondary cancers, and fertility issues. These are long-term effects.

Long-term Health Monitoring

Monitoring is vital for Wilms tumor survivors due to long-term complications. Regular check-ups, imaging, and assessments for late effects are needed. Survivors should also get advice on a healthy lifestyle to reduce complication risks.

Understanding and tackling these complications helps in better care and support for survivors. This improves their quality of life.

Prevention and Screening Recommendations

Preventing Wilms Tumor involves several steps. We screen high-risk groups and offer genetic counseling. This helps us find Wilms Tumor early, which improves treatment chances.

Screening for High-risk Populations

Screening is key for those at high risk. This includes kids with certain genetic conditions or a family history of Wilms Tumor. Regular ultrasound checks help spot problems early.

Research shows early detection boosts survival rates. We advise regular screening for high-risk kids as part of their care.

Genetic Counseling

Genetic counseling is vital for families with Wilms Tumor history. Genetic counselors offer insights on genetic testing and its implications. This helps families make informed choices.

Knowing their genetic risk helps families decide on screening and prevention. We urge families with Wilms Tumor history to get genetic counseling. This way, they can understand their risks and options better.

Support Resources for Families

Dealing with Wilms tumor treatment is easier with the right support. Families face many challenges, from complex medical treatments to emotional struggles. These issues can be tough to handle alone.

National Organizations and Support Groups

National organizations and support groups are key in helping families. They offer educational materials, emotional support, and connections to others. This support is vital for families going through similar experiences.

  • The National Wilms Tumor Study Group (NWTSG) provides valuable resources and support for families affected by Wilms tumor.
  • The Children’s Oncology Group (COG) is another key organization that offers support and information for families dealing with Wilms tumor and other childhood cancers.

Financial and Psychological Support Services

Financial and psychological support are essential for families facing Wilms tumor treatment. Many organizations help with treatment costs, travel, and other needs. This support is vital for families during tough times.

OrganizationServices OfferedContact Information
Cancer Financial Assistance CoalitionFinancial assistance for cancer patientsVisit their website
Pediatric Cancer Research FoundationGrants for families of children with cancerVisit their website
Coping with CancerPsychological support and counselingVisit their website

These resources greatly help families with Wilms tumor. They provide the support and assistance needed during a difficult time.

Research Advancements in Wilms Tumor

New research has led to better treatments for Wilms tumor. This shift in management is thanks to ongoing studies and trials. These changes are key to better patient outcomes and less treatment side effects.

Novel Treatment Approaches

Researchers are looking into novel treatment approaches. They aim to make current treatments work better and cause less harm. This includes using more precise surgery to help patients recover faster and do better overall.

Also, clinical trials are testing new chemotherapy plans. These trials are vital for finding the best treatments. They help ensure patients get the best care possible.

Targeted Therapies and Immunotherapy

Targeted therapies are a big step forward in treating Wilms tumor. They focus on cancer cells, which means less damage to healthy tissues. This reduces the chance of long-term problems.

Immunotherapy is another exciting area. It uses the body’s immune system to fight cancer. This method has shown promise in treating Wilms tumor and other cancers by boosting the body’s defenses.

We’re hopeful that these research breakthroughs will keep improving Wilms tumor treatment. As new treatments come along, it’s important for patients and families to stay updated. They should talk to their doctors about these options.

Conclusion

Wilms tumor is a complex condition that needs a deep understanding. We’ve talked about its characteristics, diagnosis, treatment, and management. It’s clear that a team effort is key to care, with accurate diagnosis and effective treatment.

A biopsy is the primary method for diagnosing Wilms tumor.

In the end, treating Wilms tumor requires a complete care approach. This includes advances in diagnosis, treatment, and support. By sharing our knowledge, we can improve the lives of those with Wilms tumor.

FAQ

Is Wilms tumor a type of solid tumor?

Yes, Wilms tumor is a solid tumor that starts in the kidneys. It mainly affects children.

What are the characteristics of Wilms tumor as a solid tumor?

Wilms tumor has unique physical and histological features. Its growth in the kidney is key to understanding its behavior.

What is the epidemiology of Wilms tumor?

Wilms tumor shows specific patterns in its occurrence. This includes age, gender, and geographical variations.

What are the causes and risk factors for Wilms tumor?

Genetic predisposition, environmental factors, and sporadic cases are linked to Wilms tumor. These are important for understanding its development.

Diagnosing Wilms tumor uses imaging, lab tests, and biopsy. These are vital for accurate diagnosis and treatment planning.

What are the treatment strategies for Wilms tumor?

Treating Wilms tumor involves surgery, chemotherapy, and radiation. These are key for improving patient outcomes.

What is the prognosis for Wilms tumor?

The prognosis for Wilms tumor depends on the tumor stage, histology, and treatment response. These factors are critical for predicting outcomes.

What are the complications and long-term effects of Wilms tumor treatment?

Treatment for Wilms tumor can lead to complications. Long-term health monitoring is essential for providing complete care.

How can Wilms tumor be prevented or screened for?

Preventing and screening for Wilms tumor involves identifying high-risk groups. Genetic counseling is also key for early detection and intervention.

What support resources are available for families affected by Wilms tumor?

Families affected by Wilms tumor can find support through national organizations, support groups, and financial and psychological services. These are vital for holistic care.

What are the research advancements in Wilms tumor?

Research has led to new treatments for Wilms tumor, including targeted therapies and immunotherapy. These are important for improving patient outcomes.

What is the survival rate for Wilms tumor?

The survival rate for Wilms tumor varies based on the tumor stage, histology, and treatment response. Overall, survival rates are relatively high.

Can Wilms tumor be treated with targeted therapies?

Yes, targeted therapies are being explored for treating Wilms tumor. They offer new hope for better patient outcomes.

References:

  • National Cancer Institute. (2025). Wilms tumor treatment (PDQ®)–health professional version. NCI.https://www.cancer.gov/types/kidney/hp/wilms-treatment-pdq
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Liv Hospital Ulus Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics Spec. MD. Gizem Güvener Liv Hospital Ulus Spec. MD. Gizem Güvener Pediatrics Spec. MD. Osman Karlı Liv Hospital Ulus Spec. MD. Osman Karlı Pediatrics Spec. MD. Tamer Ünver Liv Hospital Ulus Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU) Assoc. Prof. MD. Adem Dursun Liv Hospital Vadistanbul Assoc. Prof. MD. Adem Dursun Pediatrics Psyc. Selenay Yücel Keleş Liv Hospital Vadistanbul Psyc. Selenay Yücel Keleş Pediatric Psychology Spec. MD.  Fatih Aydın Liv Hospital Vadistanbul Spec. MD. Fatih Aydın Pediatrics Spec. MD. Dicle Çelik Liv Hospital Vadistanbul Spec. MD. Dicle Çelik Pediatrics Spec. MD. Elif Erdem Özcan Liv Hospital Vadistanbul Spec. MD. Elif Erdem Özcan Pediatrics Spec. MD. Hilal Kızıldağ Liv Hospital Vadistanbul Spec. MD. Hilal Kızıldağ Pediatrics Spec. MD. Mehmet Kılıç Liv Hospital Vadistanbul Spec. MD. Mehmet Kılıç Pediatrics Spec. MD. Ozan Uzunhan Liv Hospital Vadistanbul Spec. MD. Ozan Uzunhan Neonatology Spec. MD. Selami Bayrakdar Liv Hospital Vadistanbul Spec. MD. Selami Bayrakdar Pediatrics Spec. MD. Semra Akkuş Akman Liv Hospital Vadistanbul Spec. MD. Semra Akkuş Akman Pediatrics Asst. Prof. MD. Doruk Gül Liv Hospital Bahçeşehir Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases Prof. MD. Murat Sütçü Liv Hospital Bahçeşehir Prof. MD. Murat Sütçü Pediatric Health and Diseases Prof. MD. Nihat Demir Liv Hospital Bahçeşehir Prof. MD. Nihat Demir Pediatrics Psyc. (Psychologist) Buse Yağmur Liv Hospital Bahçeşehir Psyc. (Psychologist) Buse Yağmur Pediatric Psychology Spec. MD. Cansu Muluk Liv Hospital Bahçeşehir Spec. MD. Cansu Muluk Pediatrics Spec. MD. Dilek Hatipoğlu Liv Hospital Bahçeşehir Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases Spec. MD. Duygu Amine Garavi Liv Hospital Bahçeşehir Spec. MD. Duygu Amine Garavi Pediatrics Spec. MD. Fatih Kaya Liv Hospital Bahçeşehir Spec. MD. Fatih Kaya Pediatric Health and Diseases Spec. MD. Günel Nüsretzade Elmar Liv Hospital Bahçeşehir Spec. MD. Günel Nüsretzade Elmar Pediatrics Spec. MD. Mey Talip Liv Hospital Bahçeşehir Spec. MD. Mey Talip Pediatric Intensive Care Spec. MD. Negın Nahanmoghaddam Liv Hospital Bahçeşehir Spec. MD. Negın Nahanmoghaddam Pediatrics Spec. MD. Nushaba Abdullayeva Liv Hospital Bahçeşehir Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases Spec. MD. Refika İlbakan Hanımeli Liv Hospital Bahçeşehir Spec. MD. Refika İlbakan Hanımeli Pediatrics Spec. MD. Selman Alazab Liv Hospital Bahçeşehir Spec. MD. Selman Alazab Pediatrics Spec. MD. Özden Durmuş Gönültaş Liv Hospital Bahçeşehir Spec. MD. Özden Durmuş Gönültaş Pediatrics Spec. Md. Öznur Ceylan Liv Hospital Bahçeşehir Spec. Md. Öznur Ceylan Pediatric Health and Diseases Assoc. Prof. MD. Aslan Yılmaz Liv Hospital Topkapı Assoc. Prof. MD. Aslan Yılmaz Neonatology Prof. MD. Alpay Çakmak Liv Hospital Topkapı Prof. MD. Alpay Çakmak Pediatrics Spec. MD. Demet Deniz Bilgin Liv Hospital Topkapı Spec. MD. Demet Deniz Bilgin Pediatrics Spec. MD. Nesrin Köseoğlu Liv Hospital Topkapı Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry Spec. MD. Seçil Sözen Liv Hospital Topkapı Spec. MD. Seçil Sözen Pediatrics Spec. MD. Özge Akça Liv Hospital Topkapı Spec. MD. Özge Akça Pediatrics Spec. MD. Şeyma Öz Liv Hospital Topkapı Spec. MD. Şeyma Öz Pediatrics Asst. Prof. MD. Pakize Elif Alkış Liv Hospital Ankara Asst. Prof. MD. Pakize Elif Alkış Pediatrics Prof. MD. Musa Kazım Çağlar Liv Hospital Ankara Prof. MD. Musa Kazım Çağlar Pediatrics Prof. MD. İbrahim Hakan Bucak Liv Hospital Ankara Prof. MD. İbrahim Hakan Bucak Pediatrics Prof.MD. Sevgi Başkan Liv Hospital Ankara Prof.MD. Sevgi Başkan Pediatrics Spec. MD. Büşra Süzen Celbek Liv Hospital Ankara Spec. MD. Büşra Süzen Celbek Pediatrics Spec. MD. Galip Erdem Liv Hospital Ankara Spec. MD. Galip Erdem Pediatrics Spec. MD. Hafsa Uçur Liv Hospital Ankara Spec. MD. Hafsa Uçur Pediatric Health and Diseases Spec. MD. Hidayet Katipoğlu Liv Hospital Ankara Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases Spec. MD. Hüsniye Altan Liv Hospital Ankara Spec. MD. Hüsniye Altan Pediatrics Spec. MD. Mehmet Turfanda Liv Hospital Ankara Spec. MD. Mehmet Turfanda Pediatric Health and Diseases Spec. MD. Mustafa Yücel Kızıltan Liv Hospital Ankara Spec. MD. Mustafa Yücel Kızıltan Pediatrics Spec. MD.  Seral Navdar Liv Hospital Gaziantep Spec. MD. Seral Navdar Pediatric Health and Diseases Spec. MD. Gül Balyemez Liv Hospital Gaziantep Spec. MD. Gül Balyemez Pediatric Health and Diseases Spec. MD. Hasan Avşar Liv Hospital Gaziantep Spec. MD. Hasan Avşar Neonatology Spec. MD. Mert Çakır Liv Hospital Gaziantep Spec. MD. Mert Çakır Pediatrics Spec. MD. Saltuk Buğra Böke Liv Hospital Gaziantep Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases Spec. MD. Özlem Karaoğlu Liv Hospital Gaziantep Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases Spec. MD. İsmail Ersan Can Liv Hospital Gaziantep Spec. MD. İsmail Ersan Can Pediatric Health and Diseases Spec. MD. Şekibe Zehra Doğan Liv Hospital Gaziantep Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases Spec. MD. Gülsenem Sarı Aracı Liv Hospital Samsun Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases Spec. MD. Nazlı Karakullukcu Çebi Liv Hospital Samsun Spec. MD. Nazlı Karakullukcu Çebi Pediatrics Spec. MD. Nezih Akgün Liv Hospital Samsun Spec. MD. Nezih Akgün Pediatric Health and Diseases Spec. MD. Pelin Aytaç Uras Liv Hospital Samsun Spec. MD. Pelin Aytaç Uras Pediatrics MD. VEFA İSAYEVA Liv Bona Dea Hospital Bakü MD. VEFA İSAYEVA Pediatric Health and Diseases Spec. MD.  Elnur Hüseynov Liv Bona Dea Hospital Bakü Spec. MD. Elnur Hüseynov Pediatrics Spec. MD. INARE ELDAROVA Liv Bona Dea Hospital Bakü Spec. MD. INARE ELDAROVA Pediatrics Spec. MD. SADİQ İSMAYILOV Liv Bona Dea Hospital Bakü Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases MD. Dr. Elnur Hüseynov MD. Dr. Elnur Hüseynov Pediatrics Spec. MD. Doğa Sevinçok Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry Spec. MD. Sadık İsmayılov Pediatrics Spec. MD. Melike Akar Liv Hospital Bahçeşehir + Liv Hospital Topkapı Spec. MD. Melike Akar Pediatrics
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics

Assoc. Prof. MD. Muhammet Ali Varkal

Liv Hospital Ulus
Spec. MD. Gizem Güvener Pediatrics

Spec. MD. Gizem Güvener

Liv Hospital Ulus
Spec. MD. Osman Karlı Pediatrics

Spec. MD. Osman Karlı

Liv Hospital Ulus
Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU)

Spec. MD. Tamer Ünver

Liv Hospital Ulus
Assoc. Prof. MD. Adem Dursun Pediatrics

Assoc. Prof. MD. Adem Dursun

Liv Hospital Vadistanbul
Psyc. Selenay Yücel Keleş Pediatric Psychology

Psyc. Selenay Yücel Keleş

Liv Hospital Vadistanbul
Spec. MD.  Fatih Aydın Pediatrics

Spec. MD. Fatih Aydın

Liv Hospital Vadistanbul
Spec. MD. Dicle Çelik Pediatrics

Spec. MD. Dicle Çelik

Liv Hospital Vadistanbul
Spec. MD. Elif Erdem Özcan Pediatrics

Spec. MD. Elif Erdem Özcan

Liv Hospital Vadistanbul
Spec. MD. Hilal Kızıldağ Pediatrics

Spec. MD. Hilal Kızıldağ

Liv Hospital Vadistanbul
Spec. MD. Mehmet Kılıç Pediatrics

Spec. MD. Mehmet Kılıç

Liv Hospital Vadistanbul
Spec. MD. Ozan Uzunhan Neonatology

Spec. MD. Ozan Uzunhan

Liv Hospital Vadistanbul
Spec. MD. Selami Bayrakdar Pediatrics

Spec. MD. Selami Bayrakdar

Liv Hospital Vadistanbul
Spec. MD. Semra Akkuş Akman Pediatrics

Spec. MD. Semra Akkuş Akman

Liv Hospital Vadistanbul
Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases

Asst. Prof. MD. Doruk Gül

Liv Hospital Bahçeşehir
Prof. MD. Murat Sütçü Pediatric Health and Diseases

Prof. MD. Murat Sütçü

Liv Hospital Bahçeşehir
Prof. MD. Nihat Demir Pediatrics

Prof. MD. Nihat Demir

Liv Hospital Bahçeşehir
Psyc. (Psychologist) Buse Yağmur Pediatric Psychology

Psyc. (Psychologist) Buse Yağmur

Liv Hospital Bahçeşehir
Spec. MD. Cansu Muluk Pediatrics

Spec. MD. Cansu Muluk

Liv Hospital Bahçeşehir
Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases

Spec. MD. Dilek Hatipoğlu

Liv Hospital Bahçeşehir
Spec. MD. Duygu Amine Garavi Pediatrics

Spec. MD. Duygu Amine Garavi

Liv Hospital Bahçeşehir
Spec. MD. Fatih Kaya Pediatric Health and Diseases

Spec. MD. Fatih Kaya

Liv Hospital Bahçeşehir
Spec. MD. Günel Nüsretzade Elmar Pediatrics

Spec. MD. Günel Nüsretzade Elmar

Liv Hospital Bahçeşehir
Spec. MD. Melike Akar Pediatrics

Spec. MD. Melike Akar

Liv Hospital Bahçeşehir
Liv Hospital Topkapı
Spec. MD. Mey Talip Pediatric Intensive Care

Spec. MD. Mey Talip

Liv Hospital Bahçeşehir
Spec. MD. Negın Nahanmoghaddam Pediatrics

Spec. MD. Negın Nahanmoghaddam

Liv Hospital Bahçeşehir
Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases

Spec. MD. Nushaba Abdullayeva

Liv Hospital Bahçeşehir
Spec. MD. Refika İlbakan Hanımeli Pediatrics

Spec. MD. Refika İlbakan Hanımeli

Liv Hospital Bahçeşehir
Spec. MD. Selman Alazab Pediatrics

Spec. MD. Selman Alazab

Liv Hospital Bahçeşehir
Spec. MD. Özden Durmuş Gönültaş Pediatrics

Spec. MD. Özden Durmuş Gönültaş

Liv Hospital Bahçeşehir
Spec. Md. Öznur Ceylan Pediatric Health and Diseases

Spec. Md. Öznur Ceylan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Aslan Yılmaz Neonatology

Assoc. Prof. MD. Aslan Yılmaz

Liv Hospital Topkapı
Prof. MD. Alpay Çakmak Pediatrics

Prof. MD. Alpay Çakmak

Liv Hospital Topkapı
Spec. MD. Demet Deniz Bilgin Pediatrics

Spec. MD. Demet Deniz Bilgin

Liv Hospital Topkapı
Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry

Spec. MD. Nesrin Köseoğlu

Liv Hospital Topkapı
Spec. MD. Seçil Sözen Pediatrics

Spec. MD. Seçil Sözen

Liv Hospital Topkapı
Spec. MD. Özge Akça Pediatrics

Spec. MD. Özge Akça

Liv Hospital Topkapı
Spec. MD. Şeyma Öz Pediatrics

Spec. MD. Şeyma Öz

Liv Hospital Topkapı
Asst. Prof. MD. Pakize Elif Alkış Pediatrics

Asst. Prof. MD. Pakize Elif Alkış

Liv Hospital Ankara
Prof. MD. Musa Kazım Çağlar Pediatrics

Prof. MD. Musa Kazım Çağlar

Liv Hospital Ankara
Prof. MD. İbrahim Hakan Bucak Pediatrics

Prof. MD. İbrahim Hakan Bucak

Liv Hospital Ankara
Prof.MD. Sevgi Başkan Pediatrics

Prof.MD. Sevgi Başkan

Liv Hospital Ankara
Spec. MD. Büşra Süzen Celbek Pediatrics

Spec. MD. Büşra Süzen Celbek

Liv Hospital Ankara
Spec. MD. Galip Erdem Pediatrics

Spec. MD. Galip Erdem

Liv Hospital Ankara
Spec. MD. Hafsa Uçur Pediatric Health and Diseases

Spec. MD. Hafsa Uçur

Liv Hospital Ankara
Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases

Spec. MD. Hidayet Katipoğlu

Liv Hospital Ankara
Spec. MD. Hüsniye Altan Pediatrics

Spec. MD. Hüsniye Altan

Liv Hospital Ankara
Spec. MD. Mehmet Turfanda Pediatric Health and Diseases

Spec. MD. Mehmet Turfanda

Liv Hospital Ankara
Spec. MD. Mustafa Yücel Kızıltan Pediatrics

Spec. MD. Mustafa Yücel Kızıltan

Liv Hospital Ankara
Spec. MD.  Seral Navdar Pediatric Health and Diseases

Spec. MD. Seral Navdar

Liv Hospital Gaziantep
Spec. MD. Gül Balyemez Pediatric Health and Diseases

Spec. MD. Gül Balyemez

Liv Hospital Gaziantep
Spec. MD. Hasan Avşar Neonatology

Spec. MD. Hasan Avşar

Liv Hospital Gaziantep
Spec. MD. Mert Çakır Pediatrics

Spec. MD. Mert Çakır

Liv Hospital Gaziantep
Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases

Spec. MD. Saltuk Buğra Böke

Liv Hospital Gaziantep
Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases

Spec. MD. Özlem Karaoğlu

Liv Hospital Gaziantep
Spec. MD. İsmail Ersan Can Pediatric Health and Diseases

Spec. MD. İsmail Ersan Can

Liv Hospital Gaziantep
Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases

Spec. MD. Şekibe Zehra Doğan

Liv Hospital Gaziantep
Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases

Spec. MD. Gülsenem Sarı Aracı

Liv Hospital Samsun
Spec. MD. Nazlı Karakullukcu Çebi Pediatrics

Spec. MD. Nazlı Karakullukcu Çebi

Liv Hospital Samsun
Spec. MD. Nezih Akgün Pediatric Health and Diseases

Spec. MD. Nezih Akgün

Liv Hospital Samsun
Spec. MD. Pelin Aytaç Uras Pediatrics

Spec. MD. Pelin Aytaç Uras

Liv Hospital Samsun
MD. VEFA İSAYEVA Pediatric Health and Diseases

MD. VEFA İSAYEVA

Liv Bona Dea Hospital Bakü
Spec. MD.  Elnur Hüseynov Pediatrics

Spec. MD. Elnur Hüseynov

Liv Bona Dea Hospital Bakü
Spec. MD. INARE ELDAROVA Pediatrics

Spec. MD. INARE ELDAROVA

Liv Bona Dea Hospital Bakü
Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases

Spec. MD. SADİQ İSMAYILOV

Liv Bona Dea Hospital Bakü
MD. Dr. Elnur Hüseynov Pediatrics

MD. Dr. Elnur Hüseynov

Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry

Spec. MD. Doğa Sevinçok

Pediatrics

Spec. MD. Sadık İsmayılov

Related Videos

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91